As per available reports about 69 relevant journals, 35 Conferences, 1597 workshops are presently dedicated exclusively to breathing disorder and about 5575 articles are being published on Infectious Diseases.

Traditional Chinese Medicine (TCM) is based on fanciful notions that ill health is caused by "imbalances" of the flow of "vital energy" (Chi or qi) through alleged pathways called meridians. The diagnoses made by its practitioners have very little to do with people's actual health problems. One study has found that acupuncture literature does not provide a consistent framework for evaluating patients, and at least seven studies have found that when multiple practitioners see the same patient, their TCM diagnoses vary considerably.

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.

Scope and Importance

TCM Concepts have little relationship to anatomy and physiology and the body processes that TCM postulates cannot be measured by scientific instruments. Researchers who examined 16 TCM acupuncture texts or treatment articles to determine the consistency of diagnosis and recommended treatment for chronic low back pain. Although 24 diagnostic patterns were described by one or more texts, only 4 patterns were described by at least half of them. Most texts (12/16) described only 3 or 4 patterns. The patterns could be categorized into 3 broad types: 1. Cold, damp, wind, heat channel obstruction patterns 2. Kidney vacuity patterns (sometimes differentiated into yang and yin patterns) 3. Blood (or blood and qi) stasis patterns. Several acupuncture points were recommended by most texts regardless of the diagnosis, whereas other acupoints were recommended for specific diagnostic patterns. There was, however, substantial variation between texts in recommended acupoints, with fewer than 20% of all acupoints recommended by half or more of the texts. The human body is an organic entity, so content here local pathological changes may affect the whole body. Moreover, the pathological changes of the internal organs may reflect on the body surface.

Market Analysis

Infectious diseases therapeutic market

The infectious diseases therapeutic market in US is estimated to grow at a rate of 3.37% between 2014- 2019. As per the records, 25% of deaths are mainly due to infectious diseases globally. Current market trend shows that North America has the more global market for infectious diseases therapeutics due to increasing incidence of infectious diseases and due to rise in aging population. Followed by North America highest global market is expected in Asia then followed by the Europe in the global infectious diseases therapeutics market. In Asia-Pacific region, China and India are expected to be the fastest growing infectious diseases therapeutics markets. The main reasons behind the highest global market of infectious diseases therapeutics market in the above countries is mainly due to large number of patients and due to increase in government funding. Some of the major companies playing a key role in the global infectious diseases therapeutics market are Merck & Co., Pfizer, Johnson & Johnson, F. Hoffmann-La Roche, GlaxoSmithKline Pharmaceutical, Inc., Auritec Pharmaceuticals, Novartis, Achillion Pharmaceuticals, Isis Pharmaceuticals and Gilead Sciences.

Infectious diseases diagnostics market

Market for infectious disease molecular diagnostics tests includes hospitals, blood banks, reference laboratories. North America has the highest global market for molecular diagnostics tests followed by Europe due to the market availability of the tests and high occurrence rate of various infectious diseases such as HPV, hepatitis and bacterial infections. Asia Pacific, Latin America and Middle East are expected to be the potential markets in the coming years. Major companies which play a key role in infectious disease molecular diagnostics tests market are Abbott Laboratories, Affymetrix, Inc., Becton, Dickinson and Company, bioMérieux, Cepheid, Inc., Hologic, Inc., Life Technologies, Myriad Genetics, Inc., Qiagen N.V. and others.